First Advantage (FA) Asset Writedowns and Impairment (2020 - 2026)
First Advantage's (FA) quarterly Asset Writedowns and Impairment came in at $572000.0 in Q1 2026, up 180.34% YoY from $204040.1 in Q1 2025, and down 18.98% on a QoQ basis from $706000.0 in Q4 2025.
First Advantage (FA) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
First Advantage (FA) has 7 years of Asset Writedowns and Impairment data on file, last reported at $572000.0 in Q1 2026.
- Quarterly Asset Writedowns and Impairment rose 180.34% year-over-year to $572000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (up 550.0% YoY) and the FY2025 annual result came in at $705000.0, up 346.2% from the prior year.
- Asset Writedowns and Impairment declined to $572000.0 in Q1 2026, from $706000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $1.5 million in Q3 2025 to a low of -$783000.0 in Q2 2025.
- A 5-year average of $93294.1 and a median of $64000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2024 — Asset Writedowns and Impairment jumped 6300.0% — and 2025, when it plunged 1679.55%.
- Tracing FA's Asset Writedowns and Impairment over 5 years: stood at $213000.0 in 2022, then plunged by 189.2% to -$190000.0 in 2023, then jumped by 134.74% to $66000.0 in 2024, then surged by 969.7% to $706000.0 in 2025, then fell by 18.98% to $572000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $572000.0 (Q1 2026), $706000.0 (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Cintas | 81.84 Bn | 81.56 Bn | 1.48 Bn |
| 2 | Relx | 65.92 Bn | 65.74 Bn | - |
| 3 | Copart | 31.68 Bn | 28.33 Bn | 732.88 Mn |
| 4 | Global Payments | 25.34 Bn | 19.93 Bn | 2.03 Bn |
| 5 | Rb Global | 16.15 Bn | 15.62 Bn | 935.50 Mn |
| 6 | Aramark | 15.72 Bn | 15.22 Bn | 430.34 Mn |
| 7 | UL Solutions | 15.16 Bn | 14.72 Bn | 417.00 Mn |
| 8 | Rentokil Initial | 11.92 Bn | 9.40 Bn | - |
| 9 | Dolby Laboratories | 6.14 Bn | 5.47 Bn | 264.68 Mn |
| 10 | First Advantage | 3.59 Bn | 3.35 Bn | 203.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 220,000.00 |
| Jun 30, 2026 | 220,000.00 |
| Mar 31, 2026 | 572,000.00 |
| Mar 31, 2026 | 572,000.00 |
| Dec 31, 2025 | 706,000.00 |
| Dec 31, 2025 | 706,000.00 |
| Sep 30, 2025 | 1.49 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | -783,000.00 |
| Jun 30, 2025 | -783,000.00 |
| Mar 31, 2025 | -712,000.00 |
| Mar 31, 2025 | -712,000.00 |
| Dec 31, 2024 | 66,000.00 |
| Dec 31, 2024 | 66,000.00 |
| Sep 30, 2024 | 248,000.00 |
| Sep 30, 2024 | 248,000.00 |
| Jun 30, 2024 | -44,000.00 |
| Jun 30, 2024 | -44,000.00 |
| Mar 31, 2024 | -112,000.00 |
| Mar 31, 2024 | -112,000.00 |